Frontline PARP inhibitor maintenance therapy in ovarian cancer: A Society of Gynecologic Oncology practice statement
Bhavana Pothuri, Roisin E. O’Cearbhaill, Ramez N. Eskander, Deborah K. Armstrong
Topics & Concepts
MedicineOvarian cancerOncologyInternal medicineCancerBRCA mutationPARP inhibitorMaintenance therapyGynecologic oncologyAdverse effectChemotherapyGeneChemistryPoly ADP ribose polymerasePolymeraseBiochemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer